DNA-PKcs Negatively Regulates Cyclin B1 Protein Stability Through Facilitating Its Ubiquitination Mediated by Cdh1-APC/C Pathway
Overview
Authors
Affiliations
The catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) is a critical component of the non-homologous end-joining pathway of DNA double-stranded break repair. DNA-PKcs has also been shown recently functioning in mitotic regulation. Here, we report that DNA-PKcs negatively regulates the stability of Cyclin B1 protein through facilitating its ubiquitination mediated by Cdh1 / E 3 ubiquitin ligase APC/C pathway. Loss of DNA-PKcs causes abnormal accumulation of Cyclin B1 protein. Cyclin B1 degradation is delayed in DNA-PKcs-deficient cells as result of attenuated ubiquitination. The impact of DNA-PKcs on Cyclin B1 stability relies on its kinase activity. Our study further reveals that DNA-PKcs interacts with APC/C core component APC2 and its co-activator Cdh1. The destruction of Cdh1 is accelerated in the absence of DNA-PKcs. Moreover, overexpression of exogenous Cdh1 can reverse the increase of Cyclin B1 protein in DNA-PKcs-deficient cells. Thus, DNA-PKcs, in addition to its direct role in DNA damage repair, functions in mitotic progression at least partially through regulating the stability of Cyclin B1 protein.
Deoxybouvardin targets EGFR, MET, and AKT signaling to suppress non-small cell lung cancer cells.
Nam A, Joo S, Khong Q, Park J, Lee N, Lee S Sci Rep. 2024; 14(1):20820.
PMID: 39242647 PMC: 11379681. DOI: 10.1038/s41598-024-70823-7.
Seo S, Joo S, Lee S, Yoon G, Cho S, Choi Y Antioxidants (Basel). 2024; 13(7).
PMID: 39061934 PMC: 11273932. DOI: 10.3390/antiox13070866.
Double-strand DNA break repair: molecular mechanisms and therapeutic targets.
Tan J, Sun X, Zhao H, Guan H, Gao S, Zhou P MedComm (2020). 2023; 4(5):e388.
PMID: 37808268 PMC: 10556206. DOI: 10.1002/mco2.388.
Javed A, Ozduman G, Varisli L, Ozturk B, Korkmaz K Biology (Basel). 2023; 12(2).
PMID: 36829467 PMC: 9952942. DOI: 10.3390/biology12020189.
DNA-PKcs: A Targetable Protumorigenic Protein Kinase.
Dylgjeri E, Knudsen K Cancer Res. 2021; 82(4):523-533.
PMID: 34893509 PMC: 9306356. DOI: 10.1158/0008-5472.CAN-21-1756.